MingCeler
Latest round
- Series A
Last raised
- Jul 2026
Total raised
- Undisclosed
Investors
- 2
About MingCeler
, trading as MingCeler, is a biotechnology company focusing on genetically engineered animal model development and next-generation laboratory animal technologies. The company is a joint incubator of Guangzhou Laboratory and Bio Island Laboratory. Its founder Guangming Wu is a researcher at Guangzhou National Laboratory and his name is on permanent display at the Deutsches Museum, Germany. The company has established AAALAC international certification and ISO quality management systems, setting industry benchmarks in product quality, research ethics, and social responsibility. MingCeler specializes in the development of genetically engineered animal models and related research services for biomedical, pharmaceutical, and life sciences applications. The company's core offering is the rapid customization of gene-edited mouse models using its proprietary TurboMice™ tetraploid complementation technology, which enables researchers to obtain homozygous genetically modified mice in significantly shorter timeframes compared to traditional breeding approaches. The company generates revenue primarily through the development and commercialization of genetically engineered animal models for biomedical research and preclinical drug development.
Who invested in MingCeler
2 investors across 1 round
See all investors in MingCeler
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 13, 2026
Amount
Undisclosed
Investors
Questions about MingCeler
Who invested in MingCeler?
MingCeler has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MingCeler raised?
MingCeler has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did MingCeler last raise money?
MingCeler's most recent round on record is a Series A, in Jul 2026.
What does MingCeler do?
, trading as MingCeler, is a biotechnology company focusing on genetically engineered animal model development and next-generation laboratory animal technologies.
Where is MingCeler headquartered?
MingCeler is headquartered in Guangzhou, China.
Which VCs invest in companies like MingCeler?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at MingCeler's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like MingCeler? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.